Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nkx2-5
|
ENSMUSG00000015579.4 | NK2 homeobox 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_26850903_26851107 | Nkx2-5 | 5996 | 0.110886 | 0.43 | 1.1e-03 | Click! |
chr17_26850322_26850520 | Nkx2-5 | 5412 | 0.114123 | 0.42 | 1.5e-03 | Click! |
chr17_26841152_26841303 | Nkx2-5 | 338 | 0.803395 | 0.37 | 5.7e-03 | Click! |
chr17_26852653_26852804 | Nkx2-5 | 7719 | 0.104224 | 0.36 | 6.3e-03 | Click! |
chr17_26850000_26850151 | Nkx2-5 | 5066 | 0.116453 | 0.36 | 6.7e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_29680715_29680875 | 18.96 |
Mlana |
melan-A |
17029 |
0.18 |
chr18_36342380_36342857 | 16.75 |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
38 |
0.98 |
chr19_24049400_24049660 | 14.62 |
1700021P04Rik |
RIKEN cDNA 1700021P04 gene |
15263 |
0.16 |
chr14_66816578_66816793 | 12.36 |
Gm9130 |
predicted gene 9130 |
18307 |
0.16 |
chr7_129671765_129671934 | 12.27 |
Gm33248 |
predicted gene, 33248 |
4424 |
0.24 |
chr4_102091771_102091922 | 11.73 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
4105 |
0.26 |
chr9_37495766_37496104 | 11.43 |
Gm47963 |
predicted gene, 47963 |
1834 |
0.21 |
chr3_96564021_96564546 | 11.33 |
Gm15441 |
predicted gene 15441 |
2518 |
0.11 |
chr5_124149007_124149309 | 10.52 |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
8897 |
0.12 |
chr19_3528765_3528920 | 10.27 |
Gm48683 |
predicted gene, 48683 |
1738 |
0.28 |
chr17_28355998_28356153 | 10.14 |
Tulp1 |
tubby like protein 1 |
99 |
0.94 |
chr3_107417047_107417268 | 9.93 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
42395 |
0.12 |
chr12_77151612_77151767 | 9.76 |
Gm22696 |
predicted gene, 22696 |
35257 |
0.17 |
chr5_41621861_41622025 | 9.58 |
Rab28 |
RAB28, member RAS oncogene family |
5559 |
0.32 |
chr8_102596538_102596950 | 9.45 |
Cdh11 |
cadherin 11 |
40575 |
0.15 |
chr7_66871540_66871906 | 9.34 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
22016 |
0.2 |
chr9_59024490_59024794 | 9.31 |
Neo1 |
neogenin |
11783 |
0.24 |
chr4_102091335_102091486 | 9.28 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
3669 |
0.27 |
chr16_13946380_13946685 | 9.26 |
Mpv17l |
Mpv17 transgene, kidney disease mutant-like |
5438 |
0.13 |
chr19_21859258_21859479 | 9.24 |
Gm50130 |
predicted gene, 50130 |
25612 |
0.19 |
chr17_72275407_72275698 | 9.19 |
Gm19183 |
predicted gene, 19183 |
19294 |
0.28 |
chr17_9895279_9895715 | 9.11 |
Gm49808 |
predicted gene, 49808 |
31078 |
0.15 |
chr11_20660546_20660735 | 9.08 |
Sertad2 |
SERTA domain containing 2 |
13485 |
0.2 |
chr9_59684059_59684343 | 9.06 |
Gramd2 |
GRAM domain containing 2 |
4057 |
0.16 |
chr5_31568366_31568531 | 8.89 |
Gm43660 |
predicted gene 43660 |
624 |
0.53 |
chr7_112261296_112261450 | 8.79 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
9926 |
0.28 |
chr3_121584738_121584917 | 8.72 |
Slc44a3 |
solute carrier family 44, member 3 |
52423 |
0.09 |
chr3_132940688_132940839 | 8.71 |
Gm23196 |
predicted gene, 23196 |
893 |
0.55 |
chr3_104372484_104372636 | 8.67 |
Gm5546 |
predicted gene 5546 |
5947 |
0.17 |
chr10_61386219_61386644 | 8.64 |
Pald1 |
phosphatase domain containing, paladin 1 |
2901 |
0.16 |
chr18_24420261_24420672 | 8.62 |
Mir187 |
microRNA 187 |
8704 |
0.22 |
chr11_51469457_51469828 | 8.57 |
Col23a1 |
collagen, type XXIII, alpha 1 |
104790 |
0.05 |
chr15_30700790_30701082 | 8.56 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
17777 |
0.24 |
chr10_60186195_60186502 | 8.47 |
Chst3 |
carbohydrate sulfotransferase 3 |
2359 |
0.29 |
chrX_72761638_72761789 | 8.47 |
Gabrq |
gamma-aminobutyric acid (GABA) A receptor, subunit theta |
63465 |
0.09 |
chr8_26352467_26353019 | 8.45 |
Gm31784 |
predicted gene, 31784 |
40409 |
0.11 |
chr19_29907861_29908012 | 8.41 |
Il33 |
interleukin 33 |
17178 |
0.17 |
chr4_63685125_63685314 | 8.41 |
Gm11214 |
predicted gene 11214 |
21840 |
0.14 |
chr13_44569522_44569680 | 8.33 |
Gm34276 |
predicted gene, 34276 |
933 |
0.59 |
chr4_62477956_62478121 | 8.15 |
Bspry |
B-box and SPRY domain containing |
2015 |
0.2 |
chr11_112607463_112607614 | 8.10 |
BC006965 |
cDNA sequence BC006965 |
61860 |
0.15 |
chr18_33386598_33386796 | 8.06 |
Gm5503 |
predicted gene 5503 |
1742 |
0.46 |
chr11_90425460_90425611 | 7.99 |
Hlf |
hepatic leukemia factor |
34640 |
0.19 |
chr2_3745171_3745322 | 7.98 |
Gm13185 |
predicted gene 13185 |
9931 |
0.18 |
chr7_98775146_98775387 | 7.85 |
Gm44934 |
predicted gene 44934 |
40185 |
0.1 |
chr19_24457116_24457268 | 7.78 |
Fam122a |
family with sequence similarity 122, member A |
20164 |
0.2 |
chr4_131744439_131744590 | 7.67 |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
24407 |
0.16 |
chr17_25082565_25082748 | 7.62 |
Tmem204 |
transmembrane protein 204 |
935 |
0.41 |
chr2_65981991_65982350 | 7.60 |
Gm13617 |
predicted gene 13617 |
28100 |
0.18 |
chr13_44128967_44129144 | 7.57 |
Gm5083 |
predicted gene 5083 |
7761 |
0.18 |
chr9_67593595_67593746 | 7.53 |
Tln2 |
talin 2 |
33967 |
0.19 |
chr16_95932968_95933119 | 7.51 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
3966 |
0.21 |
chr9_92261034_92261212 | 7.50 |
Plscr1 |
phospholipid scramblase 1 |
5172 |
0.16 |
chr10_70166527_70166678 | 7.43 |
Ccdc6 |
coiled-coil domain containing 6 |
7907 |
0.23 |
chr17_6797498_6797779 | 7.40 |
Gm49717 |
predicted gene, 49717 |
6845 |
0.16 |
chr3_122058882_122059222 | 7.39 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
12476 |
0.17 |
chr11_97682543_97682929 | 7.39 |
Cisd3 |
CDGSH iron sulfur domain 3 |
3090 |
0.1 |
chr5_119813612_119813763 | 7.33 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
5818 |
0.18 |
chr9_62995124_62995631 | 7.29 |
Pias1 |
protein inhibitor of activated STAT 1 |
7453 |
0.21 |
chr16_84474776_84475094 | 7.29 |
Gm6032 |
predicted gene 6032 |
39253 |
0.15 |
chr2_119538926_119539077 | 7.28 |
Exd1 |
exonuclease 3'-5' domain containing 1 |
2512 |
0.2 |
chr1_184473956_184474164 | 7.20 |
2900092O11Rik |
RIKEN cDNA 2900092O11 gene |
31080 |
0.17 |
chr5_36385148_36385489 | 7.20 |
Sorcs2 |
sortilin-related VPS10 domain containing receptor 2 |
12789 |
0.2 |
chr2_75772672_75773085 | 7.14 |
Gm13657 |
predicted gene 13657 |
4310 |
0.17 |
chr5_77129945_77130248 | 7.07 |
Gm15831 |
predicted gene 15831 |
7748 |
0.13 |
chr2_44286375_44286600 | 7.05 |
Gm22867 |
predicted gene, 22867 |
142448 |
0.05 |
chr15_62986346_62986501 | 7.04 |
Tsg101-ps |
tumor susceptibility gene 101, pseudogene |
5775 |
0.32 |
chr3_86003005_86003351 | 7.04 |
Prss48 |
protease, serine 48 |
687 |
0.6 |
chr13_98107739_98107890 | 7.03 |
Arhgef28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
68173 |
0.11 |
chr6_92854831_92854982 | 7.02 |
Adamts9 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
274 |
0.92 |
chr12_25293896_25294068 | 6.98 |
Gm36723 |
predicted gene, 36723 |
9958 |
0.18 |
chr7_84128588_84129123 | 6.98 |
Abhd17c |
abhydrolase domain containing 17C |
18960 |
0.14 |
chr5_150457458_150457743 | 6.94 |
Fry |
FRY microtubule binding protein |
111 |
0.94 |
chr12_70799430_70799753 | 6.94 |
Gm40437 |
predicted gene, 40437 |
25754 |
0.16 |
chr7_81726584_81726917 | 6.91 |
Gm18806 |
predicted gene, 18806 |
15595 |
0.11 |
chr11_59645145_59645320 | 6.87 |
Mprip |
myosin phosphatase Rho interacting protein |
16073 |
0.12 |
chr17_70369247_70369447 | 6.83 |
Dlgap1 |
DLG associated protein 1 |
55447 |
0.17 |
chr4_40868987_40869196 | 6.82 |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
15086 |
0.1 |
chr2_17715540_17715691 | 6.81 |
Nebl |
nebulette |
15428 |
0.25 |
chr8_33905789_33906327 | 6.80 |
Rbpms |
RNA binding protein gene with multiple splicing |
14294 |
0.16 |
chr9_99709702_99709863 | 6.80 |
Cldn18 |
claudin 18 |
227 |
0.89 |
chr2_26573268_26573443 | 6.80 |
Egfl7 |
EGF-like domain 7 |
6659 |
0.09 |
chr9_47414695_47414893 | 6.71 |
Gm31816 |
predicted gene, 31816 |
46145 |
0.14 |
chr17_7851979_7852315 | 6.70 |
Fndc1 |
fibronectin type III domain containing 1 |
24845 |
0.19 |
chr4_65671658_65671811 | 6.70 |
Trim32 |
tripartite motif-containing 32 |
66485 |
0.15 |
chr15_96973035_96973217 | 6.68 |
Slc38a4 |
solute carrier family 38, member 4 |
46825 |
0.15 |
chr5_115545813_115545975 | 6.68 |
Pxn |
paxillin |
590 |
0.57 |
chr18_53498288_53498518 | 6.68 |
Prdm6 |
PR domain containing 6 |
25422 |
0.23 |
chr3_121559557_121559708 | 6.65 |
Slc44a3 |
solute carrier family 44, member 3 |
27228 |
0.14 |
chr6_121209715_121209869 | 6.64 |
Tuba8 |
tubulin, alpha 8 |
904 |
0.46 |
chr1_74624463_74624614 | 6.63 |
Stk36 |
serine/threonine kinase 36 |
1708 |
0.24 |
chr5_118981037_118981522 | 6.62 |
Gm43784 |
predicted gene 43784 |
15717 |
0.19 |
chr4_58699399_58699550 | 6.59 |
Gm12580 |
predicted gene 12580 |
40882 |
0.15 |
chr5_112623019_112623245 | 6.58 |
4933415J04Rik |
RIKEN cDNA 4933415J04 gene |
17203 |
0.13 |
chr18_39881257_39881408 | 6.57 |
Gm41708 |
predicted gene, 41708 |
48042 |
0.17 |
chr18_70103999_70104315 | 6.57 |
Gm50219 |
predicted gene, 50219 |
33934 |
0.17 |
chr19_3995581_3995732 | 6.56 |
Tbx10 |
T-box 10 |
2904 |
0.08 |
chr12_76299439_76299778 | 6.55 |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
2093 |
0.19 |
chr4_155019587_155019765 | 6.55 |
Plch2 |
phospholipase C, eta 2 |
244 |
0.89 |
chr7_119608235_119608390 | 6.52 |
Acsm1 |
acyl-CoA synthetase medium-chain family member 1 |
1286 |
0.29 |
chr2_32455207_32455358 | 6.52 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
3837 |
0.12 |
chr5_31931244_31931395 | 6.47 |
Gm43811 |
predicted gene 43811 |
4622 |
0.27 |
chr5_46830784_46831330 | 6.46 |
Gm43092 |
predicted gene 43092 |
36377 |
0.24 |
chr16_38624391_38624551 | 6.39 |
Tmem39a |
transmembrane protein 39a |
36432 |
0.12 |
chr19_36167625_36167790 | 6.38 |
Gm32081 |
predicted gene, 32081 |
14873 |
0.19 |
chr5_103387516_103387737 | 6.33 |
5430427N15Rik |
RIKEN cDNA 5430427N15 gene |
30928 |
0.13 |
chr12_56515019_56515170 | 6.33 |
Sfta3-ps |
surfactant associated 3, pseudogene |
3050 |
0.17 |
chr5_127310428_127310665 | 6.33 |
9430087B13Rik |
RIKEN cDNA 9430087B13 gene |
1529 |
0.44 |
chr5_90790262_90790489 | 6.32 |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
4159 |
0.11 |
chr12_108865341_108865493 | 6.31 |
Gm22079 |
predicted gene, 22079 |
2748 |
0.14 |
chrX_7690587_7690738 | 6.30 |
Gm6079 |
predicted gene 6079 |
3711 |
0.09 |
chr13_3357628_3357805 | 6.29 |
Gm16505 |
predicted gene 16505 |
557 |
0.51 |
chr6_145769035_145769220 | 6.28 |
Rassf8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
18556 |
0.18 |
chr6_135017441_135017592 | 6.27 |
Ddx47 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 |
1484 |
0.34 |
chr12_40826584_40826738 | 6.25 |
Dock4 |
dedicator of cytokinesis 4 |
32427 |
0.16 |
chr10_77869773_77869924 | 6.25 |
Tspear |
thrombospondin type laminin G domain and EAR repeats |
5225 |
0.07 |
chr11_70130078_70130425 | 6.24 |
Mgl2 |
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
78 |
0.91 |
chr19_34569115_34569266 | 6.22 |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
14341 |
0.1 |
chr11_51468858_51469078 | 6.21 |
Col23a1 |
collagen, type XXIII, alpha 1 |
105464 |
0.05 |
chr13_93992771_93993277 | 6.19 |
Gm47216 |
predicted gene, 47216 |
1256 |
0.46 |
chr1_40183668_40183819 | 6.18 |
Il1r1 |
interleukin 1 receptor, type I |
41337 |
0.14 |
chr2_152481911_152482062 | 6.18 |
Defb20 |
defensin beta 20 |
4923 |
0.09 |
chr6_5553793_5553944 | 6.17 |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
57559 |
0.15 |
chr7_43713797_43713948 | 6.17 |
Klk13 |
kallikrein related-peptidase 13 |
473 |
0.59 |
chr9_110689249_110689827 | 6.17 |
Gm35715 |
predicted gene, 35715 |
14584 |
0.1 |
chr4_54972149_54972300 | 6.16 |
Zfp462 |
zinc finger protein 462 |
24248 |
0.23 |
chr3_30503986_30504161 | 6.14 |
Gm37652 |
predicted gene, 37652 |
260 |
0.89 |
chr15_76455983_76456154 | 6.12 |
Bop1 |
block of proliferation 1 |
40 |
0.93 |
chr16_92294277_92294563 | 6.10 |
Kcne2 |
potassium voltage-gated channel, Isk-related subfamily, gene 2 |
1196 |
0.35 |
chr11_8674638_8674812 | 6.09 |
Tns3 |
tensin 3 |
10044 |
0.3 |
chr16_95244705_95244856 | 6.08 |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
12778 |
0.19 |
chr10_95385743_95386313 | 6.08 |
Socs2 |
suppressor of cytokine signaling 2 |
6939 |
0.14 |
chr18_75362937_75363258 | 6.05 |
Gm20544 |
predicted gene 20544 |
3991 |
0.23 |
chr2_167235356_167235725 | 6.04 |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
5049 |
0.16 |
chr11_90425774_90425927 | 6.03 |
Hlf |
hepatic leukemia factor |
34955 |
0.19 |
chr7_112289469_112289834 | 5.99 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
18352 |
0.26 |
chr11_94495552_94495761 | 5.99 |
Epn3 |
epsin 3 |
2594 |
0.18 |
chr12_91966067_91966218 | 5.97 |
Gm21614 |
predicted gene, 21614 |
3435 |
0.23 |
chr6_113686612_113686770 | 5.96 |
Gm43912 |
predicted gene, 43912 |
3164 |
0.09 |
chr11_9932975_9933142 | 5.92 |
Eif3s6-ps1 |
eukaryotic translation initiation factor 3, subunit 6, pseudogene 1 |
195437 |
0.03 |
chr9_32314102_32314486 | 5.92 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
29943 |
0.14 |
chrX_56651870_56652063 | 5.91 |
Slc9a6 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 |
6118 |
0.19 |
chr12_12509201_12509901 | 5.91 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
116936 |
0.06 |
chr7_16583787_16584087 | 5.91 |
Gm29443 |
predicted gene 29443 |
29887 |
0.08 |
chr12_55114139_55114290 | 5.89 |
Fam177a |
family with sequence similarity 177, member A |
10255 |
0.11 |
chr13_42878489_42878640 | 5.88 |
Gm15812 |
predicted gene 15812 |
8962 |
0.22 |
chr15_101410875_101411229 | 5.88 |
Krt7 |
keratin 7 |
0 |
0.93 |
chr10_42148490_42148656 | 5.87 |
Tdg-ps2 |
thymine DNA glycosylase, pseudogene 2 |
93267 |
0.07 |
chr11_61196734_61196885 | 5.86 |
Rps13-ps5 |
ribosomal protein S13, pseudogene 5 |
9366 |
0.14 |
chr7_70575738_70576033 | 5.85 |
Gm44812 |
predicted gene 44812 |
599 |
0.65 |
chr5_136403565_136403754 | 5.82 |
Mir721 |
microRNA 721 |
27856 |
0.15 |
chr16_16262555_16262706 | 5.80 |
Gm5481 |
predicted gene 5481 |
12973 |
0.16 |
chr5_112001700_112002600 | 5.80 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr12_55189203_55189354 | 5.79 |
Srp54b |
signal recognition particle 54B |
9088 |
0.11 |
chr3_143078355_143078668 | 5.79 |
Gm43614 |
predicted gene 43614 |
29437 |
0.18 |
chr11_85843373_85844045 | 5.78 |
Gm11444 |
predicted gene 11444 |
6624 |
0.13 |
chr6_30622158_30622633 | 5.77 |
Cpa5 |
carboxypeptidase A5 |
9840 |
0.12 |
chr12_102262930_102263081 | 5.77 |
Gm25203 |
predicted gene, 25203 |
9318 |
0.21 |
chr7_105621908_105622059 | 5.76 |
Gm45632 |
predicted gene 45632 |
2721 |
0.12 |
chr13_119263615_119263950 | 5.76 |
Gm44488 |
predicted gene, 44488 |
5822 |
0.24 |
chr1_155170040_155170199 | 5.75 |
Gm8850 |
predicted gene 8850 |
9682 |
0.14 |
chr9_21021465_21021760 | 5.75 |
Icam1 |
intercellular adhesion molecule 1 |
5627 |
0.07 |
chr16_92687053_92687204 | 5.74 |
Runx1 |
runt related transcription factor 1 |
8367 |
0.25 |
chr10_83328918_83329069 | 5.72 |
Gm47170 |
predicted gene, 47170 |
3731 |
0.2 |
chr9_79997288_79997439 | 5.72 |
Gm8131 |
predicted gene 8131 |
6475 |
0.18 |
chr12_55263514_55263665 | 5.72 |
Gm49376 |
predicted gene, 49376 |
11792 |
0.11 |
chr17_73022390_73023322 | 5.72 |
Gm30420 |
predicted gene, 30420 |
6222 |
0.24 |
chr17_83873426_83873775 | 5.70 |
C430042M11Rik |
RIKEN cDNA C430042M11 gene |
19182 |
0.14 |
chr15_60618977_60619128 | 5.69 |
Gm48946 |
predicted gene, 48946 |
51291 |
0.14 |
chr19_14642783_14642952 | 5.67 |
Gm37997 |
predicted gene, 37997 |
15800 |
0.24 |
chr6_92468381_92468552 | 5.65 |
Prickle2 |
prickle planar cell polarity protein 2 |
12926 |
0.26 |
chr15_52776567_52776718 | 5.63 |
Gm34794 |
predicted gene, 34794 |
9625 |
0.28 |
chr8_120001973_120002124 | 5.63 |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
678 |
0.67 |
chr9_56260137_56260407 | 5.62 |
Peak1os |
pseudopodium-enriched atypical kinase 1, opposite strand |
2382 |
0.2 |
chr14_27242296_27242447 | 5.61 |
Gm49616 |
predicted gene, 49616 |
4309 |
0.21 |
chr13_41345941_41346221 | 5.61 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
13166 |
0.14 |
chr14_105800232_105800526 | 5.61 |
Gm22406 |
predicted gene, 22406 |
16529 |
0.22 |
chr3_86057555_86057706 | 5.60 |
Sh3d19 |
SH3 domain protein D19 |
13285 |
0.14 |
chr3_97039722_97039880 | 5.58 |
Gja5 |
gap junction protein, alpha 5 |
7385 |
0.17 |
chr16_18894152_18894303 | 5.58 |
Hira |
histone cell cycle regulator |
16815 |
0.12 |
chr1_78338000_78338207 | 5.57 |
Gm28410 |
predicted gene 28410 |
2003 |
0.32 |
chr17_11656513_11656664 | 5.57 |
Gm10513 |
predicted gene 10513 |
75757 |
0.11 |
chr2_77080730_77080881 | 5.56 |
Gm44360 |
predicted gene, 44360 |
6453 |
0.24 |
chrX_96134190_96134604 | 5.56 |
Gm24718 |
predicted gene, 24718 |
16575 |
0.18 |
chr5_136394928_136395103 | 5.55 |
Mir721 |
microRNA 721 |
19212 |
0.16 |
chr16_95332303_95332454 | 5.55 |
Gm31641 |
predicted gene, 31641 |
23298 |
0.18 |
chr1_87409463_87409614 | 5.54 |
Gigyf2 |
GRB10 interacting GYF protein 2 |
2159 |
0.22 |
chr12_12354415_12354566 | 5.54 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
38125 |
0.2 |
chr17_14540365_14540534 | 5.54 |
Gm38551 |
predicted gene, 38551 |
90878 |
0.07 |
chr1_118480880_118481748 | 5.52 |
Clasp1 |
CLIP associating protein 1 |
725 |
0.54 |
chr10_120914717_120915223 | 5.51 |
Gm16166 |
predicted gene 16166 |
13216 |
0.13 |
chr5_122094478_122094843 | 5.51 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
6291 |
0.15 |
chr11_19455976_19456277 | 5.50 |
Gm12026 |
predicted gene 12026 |
72441 |
0.11 |
chr8_114527002_114527162 | 5.50 |
Gm16116 |
predicted gene 16116 |
67818 |
0.11 |
chr13_100511158_100511309 | 5.49 |
Gtf2h2 |
general transcription factor II H, polypeptide 2 |
18654 |
0.12 |
chr11_103003187_103003338 | 5.49 |
Mir6931 |
microRNA 6931 |
3341 |
0.15 |
chr7_138373550_138373701 | 5.49 |
Tcerg1l |
transcription elongation regulator 1-like |
24103 |
0.22 |
chr1_76032049_76032200 | 5.49 |
Gm29065 |
predicted gene 29065 |
13368 |
0.27 |
chr5_99190924_99191161 | 5.48 |
Gm43251 |
predicted gene 43251 |
19621 |
0.21 |
chr7_144569553_144569764 | 5.46 |
Faddos |
Fas (TNFRSF6)-associated via death domain, opposite strand |
2303 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
3.5 | 10.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.7 | 8.0 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.3 | 11.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.2 | 8.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.9 | 7.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.9 | 5.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.8 | 3.7 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.8 | 5.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.7 | 5.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.6 | 6.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.5 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.5 | 3.1 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.5 | 7.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.4 | 4.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.4 | 2.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 2.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.4 | 2.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.3 | 2.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 6.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
1.2 | 3.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.2 | 7.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.2 | 3.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.2 | 3.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.2 | 2.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.1 | 3.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 3.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.1 | 3.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.1 | 4.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.1 | 5.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.1 | 2.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.1 | 7.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.1 | 7.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.0 | 1.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.0 | 4.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.0 | 3.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 3.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 5.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.0 | 1.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 3.9 | GO:0060437 | lung growth(GO:0060437) |
1.0 | 4.8 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.0 | 2.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.9 | 0.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.9 | 3.8 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.9 | 3.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.9 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.9 | 2.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.9 | 1.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 2.7 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 5.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.9 | 1.8 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.9 | 2.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 0.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.9 | 4.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.8 | 4.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 3.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.8 | 2.5 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.8 | 4.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.8 | 3.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.8 | 1.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 2.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.8 | 1.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 4.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 3.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 5.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.8 | 2.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 2.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.8 | 1.5 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 3.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.8 | 2.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 3.0 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.8 | 2.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.8 | 8.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.7 | 2.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 3.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 1.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.7 | 2.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.9 | GO:0048793 | pronephros development(GO:0048793) |
0.7 | 0.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.7 | 1.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.7 | 2.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.7 | 2.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.7 | 3.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.7 | 4.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.7 | 2.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.7 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 4.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 0.7 | GO:1900211 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.7 | 1.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.7 | 2.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 1.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 1.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 5.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.6 | 1.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 3.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 1.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 0.6 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.6 | 2.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 1.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 0.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.6 | 3.1 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.6 | 3.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.6 | 1.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 3.0 | GO:0030578 | PML body organization(GO:0030578) |
0.6 | 2.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.6 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 4.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 5.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 0.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 1.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 2.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 1.8 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.6 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 4.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 2.3 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.6 | 2.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.6 | 1.1 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.6 | 1.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 2.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.6 | 2.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 5.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.6 | 1.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 4.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 1.7 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 2.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.6 | 1.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 2.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.6 | 1.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.6 | 0.6 | GO:0003166 | bundle of His development(GO:0003166) |
0.6 | 2.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 1.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 1.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 3.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 2.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.5 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 5.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.5 | 1.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 2.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 1.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 2.6 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 0.5 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 2.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 1.0 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.5 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.5 | 1.5 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.5 | 0.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 3.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 1.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 0.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.5 | 1.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.5 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 9.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.5 | 2.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 0.5 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.5 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 3.3 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 0.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 0.9 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 0.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.5 | 4.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.5 | 1.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.5 | 0.5 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 0.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 0.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.5 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.5 | 0.5 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 1.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 2.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 0.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 0.9 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 2.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 3.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.4 | 2.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 4.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 0.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.4 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 1.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 3.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 3.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 0.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 1.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.8 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.4 | 5.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 1.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 1.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 0.8 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 3.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 7.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 0.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 2.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.4 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 1.6 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.4 | 0.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 1.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 1.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 3.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.4 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.5 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 1.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 1.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.4 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 5.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 1.9 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 2.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 1.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.4 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 0.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 0.4 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 2.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 2.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 1.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 0.7 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.4 | 3.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 3.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 2.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 2.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 1.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 1.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 5.5 | GO:0009648 | photoperiodism(GO:0009648) |
0.3 | 3.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 15.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.3 | 1.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 2.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.4 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.3 | 3.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 1.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.0 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.3 | 0.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 1.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 1.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 1.6 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 3.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 1.0 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 1.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 1.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 0.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 1.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 1.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 1.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 0.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 3.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.3 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.3 | 2.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.3 | 0.9 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 2.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 0.9 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 0.9 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.3 | 0.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 2.7 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.3 | 1.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 0.6 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.3 | 0.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 2.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 2.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.9 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 3.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 2.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 0.3 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 4.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 0.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.3 | 1.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 2.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.3 | 0.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 2.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.6 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.3 | 1.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 9.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.3 | 2.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 0.8 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.3 | 0.6 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.3 | 1.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 0.6 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.3 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.6 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.3 | 4.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 3.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 2.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 8.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.3 | 2.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.3 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.3 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 0.5 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.3 | 0.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 2.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 4.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 2.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.5 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 1.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 1.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 1.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 1.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 1.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 0.7 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 2.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 4.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.2 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.2 | 0.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 3.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 4.3 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 0.5 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 1.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.5 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.2 | 2.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.5 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.9 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.9 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.6 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 1.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.7 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 2.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.6 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 0.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 12.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 2.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 2.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.2 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 1.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 2.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.8 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 0.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 2.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 1.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 0.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.2 | GO:1904746 | negative regulation of apoptotic process involved in development(GO:1904746) |
0.2 | 2.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 0.2 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 4.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 1.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 1.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 2.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.4 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 7.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 2.1 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 1.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.4 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.8 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 2.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 1.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.4 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 2.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.3 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.2 | 0.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 1.6 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 0.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.7 | GO:1903799 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 1.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.5 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.2 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 0.6 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 0.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.2 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.2 | 0.5 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.5 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.2 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0019740 | nitrogen utilization(GO:0019740) ammonium transmembrane transport(GO:0072488) |
0.2 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.5 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 1.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 1.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 2.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.3 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.1 | 0.4 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 2.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.1 | 0.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.9 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 8.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 3.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.5 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 1.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.6 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 1.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.7 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.5 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 2.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 2.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.6 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.2 | GO:0015802 | basic amino acid transport(GO:0015802) arginine transport(GO:0015809) |
0.1 | 2.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 3.4 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.4 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.4 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.3 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 9.4 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.6 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.1 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.6 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 1.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.5 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.4 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.5 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 2.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.9 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 1.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 1.0 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.3 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.5 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.6 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 3.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.4 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.2 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.1 | 0.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 2.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 1.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.0 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.0 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.3 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.0 | 0.3 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.2 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.0 | 1.4 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.0 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.8 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.0 | GO:0072172 | mesonephric tubule formation(GO:0072172) nephric duct formation(GO:0072179) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) regulation of chloride transport(GO:2001225) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.2 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.9 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.2 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.4 | 5.6 | GO:0070545 | PeBoW complex(GO:0070545) |
1.4 | 12.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.3 | 4.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.3 | 6.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.2 | 2.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 3.5 | GO:0097513 | myosin II filament(GO:0097513) |
1.2 | 3.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.1 | 3.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.1 | 6.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 3.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.0 | 6.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 3.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 3.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 2.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 3.3 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 2.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 2.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 2.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 3.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 2.0 | GO:0043256 | laminin-5 complex(GO:0005610) laminin complex(GO:0043256) |
0.6 | 1.9 | GO:0044393 | microspike(GO:0044393) |
0.6 | 2.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 2.5 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 3.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 2.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 33.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 5.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 5.8 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 2.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 2.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 6.1 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 7.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 9.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 1.8 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 2.2 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 1.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 3.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 3.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 2.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 7.7 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 1.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 1.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 12.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 2.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 25.4 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 2.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 3.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 4.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 2.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 9.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 1.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 1.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 8.7 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 4.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 5.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 5.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 1.3 | GO:0005818 | aster(GO:0005818) |
0.3 | 1.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 2.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 3.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 66.1 | GO:0030055 | cell-substrate adherens junction(GO:0005924) cell-substrate junction(GO:0030055) |
0.2 | 1.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 3.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 22.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 4.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 4.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 8.2 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 10.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.8 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.1 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.6 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 5.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 3.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 30.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 5.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 2.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 5.6 | GO:0005901 | caveola(GO:0005901) |
0.1 | 4.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 3.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 9.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 4.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 2.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 6.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 4.8 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.5 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 13.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 1.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 2.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.0 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 2.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.0 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.6 | 8.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.5 | 1.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.4 | 4.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.4 | 4.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.4 | 9.5 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.3 | 3.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.2 | 3.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.2 | 4.6 | GO:0042731 | PH domain binding(GO:0042731) |
1.1 | 9.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.1 | 5.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.0 | 3.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.0 | 3.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 1.0 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.0 | 2.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 6.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 3.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 9.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 4.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 8.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 2.5 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 3.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 2.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.7 | 2.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 7.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.6 | 3.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 1.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 1.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 2.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 1.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 1.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.6 | 9.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 2.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 7.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 1.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 1.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 1.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 6.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 7.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.5 | 1.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 2.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 2.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 3.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 2.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 6.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 3.4 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 2.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 4.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 2.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 1.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 1.4 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.5 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 2.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 3.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 4.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 3.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 2.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 5.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 11.4 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 4.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 2.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 2.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 3.2 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 2.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 2.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 1.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 3.7 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.4 | 1.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 2.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.4 | 1.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 0.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.4 | 4.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 6.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 6.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 3.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 9.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 1.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 3.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 2.9 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 4.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 7.9 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 5.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 2.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 16.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 3.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 1.5 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 2.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 10.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 2.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 3.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 10.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 2.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.3 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.3 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 2.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 3.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.1 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 4.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 7.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 2.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 16.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 11.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 2.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 18.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.7 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 2.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 5.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.7 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 1.3 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 8.5 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.4 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 4.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 35.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 4.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 5.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 2.8 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 3.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 3.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.5 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.8 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 17.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 9.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 3.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.8 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 2.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 1.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 3.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 3.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 1.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 2.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.2 | GO:0034895 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 2.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 4.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 2.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.9 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.8 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 2.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 1.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.5 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 1.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 2.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.8 | 19.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 3.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 15.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 6.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 3.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 18.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 16.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 4.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 7.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 7.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 2.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 4.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 8.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 3.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 12.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 4.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 45.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 1.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 7.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 10.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 4.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 5.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 6.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 2.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 6.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 7.2 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 5.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 20.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 5.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.9 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 3.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 21.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 14.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 1.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.8 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.9 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.5 | 8.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 2.0 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.5 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 21.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 5.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 3.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 1.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 5.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 1.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 7.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 6.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 23.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 5.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 2.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 1.8 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.3 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 29.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 2.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 2.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 1.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 5.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 6.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 13.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 3.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 3.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 3.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 5.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 3.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.6 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.2 | 1.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 4.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 6.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 2.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 8.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.8 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 4.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 4.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 4.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.7 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |